Wasatch Advisors’s Usana Health Sciences USNA Stock Holding History

Wasatch Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-90,160	Closed	-$7.08M	–	260
2019 Q4	$7.08M	Sell	90,160 -15,751	-15%	-$1.16M	0.06%	172
2019 Q3	$7.24M	Buy	105,911 +9,464	+10%	+$635K	0.07%	157
2019 Q2	$7.66M	Buy	96,447 +53,960	+127%	+$4.28M	0.07%	146
2019 Q1	$3.56M	Hold	42,487	–	–	0.04%	191
2018 Q4	$5M	Buy	+42,487	New	+$4.91M	0.07%	158
2014 Q4	–	Sell	-157,300	Closed	-$5.79M	–	393
2014 Q3	$5.79M	Sell	157,300 -109,474	-41%	-$3.95M	0.06%	230
2014 Q2	$10.4M	Buy	266,774 +54,592	+26%	+$2.03M	0.1%	200
2014 Q1	$7.99M	Buy	212,182 +14,918	+8%	+$521K	0.08%	214
2013 Q4	$7.46M	Buy	197,264 +83,184	+73%	+$3.18M	0.07%	216
2013 Q3	$4.95M	Sell	114,080 -49,140	-30%	-$1.97M	0.05%	244
2013 Q2	$5.91M	Buy	+163,220	New	+$4.96M	0.06%	240

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wasatch Advisors's USNA Position: Q1 2020 in Review

Wasatch Advisors sold out of Usana Health Sciences (USNA) in Q1 2020, closing a stake of 90,160 shares — an estimated $7.08M sold.

Wasatch Advisors first reported a position in USNA in Q2 2013 and held it in 11 quarters. The position peaked at $10.4M in Q2 2014. 169 funds tracked by Wall St. Rank hold USNA as of Q1 2020.

Wasatch Advisors reported no remaining Usana Health Sciences position as of Q1 2020 after selling out during the quarter.
Wasatch Advisors sold 90,160 Usana Health Sciences shares in Q1 2020, an estimated $7.08M.
Wasatch Advisors first reported a position in Usana Health Sciences in Q2 2013 and held it in 11 quarters.
Wasatch Advisors's Usana Health Sciences position peaked at $10.4M in Q2 2014.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2020.

Based on Wasatch Advisors's 13F filing for Q1 2020, filed 8 May 2020.